More about

Schizophrenia

News
December 27, 2022
1 min read
Save

Partnership expands to develop new prescription digital therapeutic for schizophrenia

Boehringer Ingelheim and Click Therapeutics have announced the launch of an expanded collaboration for development and commercialization of a second prescription digital therapeutic for those diagnosed with schizophrenia.

News
December 23, 2022
2 min read
Save

Dietary intervention may improve cardiometabolic health in schizophrenia

A nutritional program that focused on increased intake of prebiotics and probiotics improved cardiometabolic health in patients with schizophrenia spectrum disorders, according to a study published in BMC Psychiatry.

News
December 13, 2022
2 min read
Save

Deep learning may help predict mental disorder diagnosis

A multidiagnostic prediction model developed using deep learning was highly predictive of mental disorder diagnosis, according to new data published in JAMA Psychiatry.

News
November 21, 2022
2 min read
Save

Tremor, restless legs syndrome, schizophrenia among risk factors linked to PD

An increased risk for Parkinson’s disease was associated with a range of factors, comorbidities and prodromal features, some of which may appear 5 to 10 years prior to diagnosis, according to a study in JAMA Neurology.

News
November 09, 2022
1 min read
Save

Teva refiles NDA for schizophrenia treatment

Teva Pharmaceuticals announced it recently completed resubmission of a new drug application to the FDA for mdc-IRM, a risperidone subcutaneous long-acting injectable for the treatment of schizophrenia.

News
September 22, 2022
1 min read
Save

Relapse of schizophrenia in US veterans linked to higher rate of adverse social outcomes

In a cohort of United States military veterans, relapse of schizophrenia symptoms was associated with higher rates of adverse socioeconomic outcomes, according to a study published in the Journal of Clinical Psychiatry.

News
September 14, 2022
1 min read
Save

FDA accepts NDA for 2-month injectable to treat schizophrenia, bipolar disorder in adults

The FDA has accepted a new drug application for aripiprazole, a 2-month, ready-to-use, long-acting injectable for the treatment of schizophrenia in adults and maintenance monotherapy treatment of bipolar I disorder in adults.

News
August 25, 2022
1 min read
Save

Examination of brain’s electrical signals may be key to treating epilepsy, schizophrenia

Researchers at Aston University in England have received funding to explore new methods of recording electrical signals emitted from brain cells, which could lead to potential treatment for conditions like epilepsy and schizophrenia.

News
August 10, 2022
1 min read
Save

Karuna Therapeutics announces results from phase 3 trial of schizophrenia treatment

Karuna Therapeutics Inc. announced positive results from its phase 3 EMERGENT-2 trial evaluating the efficacy, safety and tolerability of its investigational therapy for adults with schizophrenia.

News
June 22, 2022
2 min read
Save

Patients with schizophrenia face more educational obstacles in higher-income nations

Despite advances in treatment, patients with schizophrenia have faced obstacles in obtaining an education, with the largest gap occurring in high-income countries, according to a study published in Lancet Psychiatry.

View more